 Such an ineffective vaccine could also lead to faster disease progression than in unvaccinated individuals.A successful vaccine would, therefore, have to incorporate viral epitopes derived from several viral subtypes.Increasing rates of antiretroviral therapy (ART) use have led to concerns about the development of drug-resistant strains which could be transmitted through superinfection.